Dermapharm Holding SE
FSX:DMP.DE
30.8 (EUR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| 62.368 | 216.297 | 292.977 | 125.283 | 110.066 | 75.226 | 77.744 | 17.064 | 12.899 | 0.237 |
| Depreciation & Amortization
| 104.587 | 94.909 | 55.159 | 47.423 | 47.877 | 30.326 | 15.861 | 14.103 | 15.059 | 18.426 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 7.19 | -4.138 | -46.271 | -13.81 | -15.261 | 73.979 | -9.218 | 1.834 | -31.707 | -20.329 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 1.856 | -8.737 | 5.423 | -0.434 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 4.781 | -6.078 | -5.354 | -3.291 |
| Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | -1.155 | 5.51 | -9.086 | 0 |
| Other Working Capital
| 9.042 | -4.138 | -46.271 | -13.81 | -15.261 | 44.968 | -13.999 | 7.912 | -26.353 | -17.038 |
| Other Non Cash Items
| 226.116 | -18.535 | -51.497 | -27.798 | -42.068 | -20.403 | 2.349 | 43.777 | 44.126 | 55.922 |
| Operating Cash Flow
| 191.087 | 288.533 | 250.368 | 131.098 | 100.614 | 159.128 | 86.736 | 76.778 | 40.377 | 54.256 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -41.541 | -39.014 | -61.203 | -40.796 | -46.442 | -25.973 | -74.715 | -17.758 | -14.933 | -28.424 |
| Acquisitions Net
| -386.578 | -69.786 | -22.511 | -68.828 | -277.317 | -85.864 | -13.715 | -1.42 | -11.74 | 0 |
| Purchases Of Investments
| 0 | -6.068 | -48.253 | 0 | -60.349 | -0.211 | -0.035 | -0.052 | -1.069 | 0 |
| Sales Maturities Of Investments
| 7.948 | 10 | 61.203 | 0 | 0.497 | 2.064 | -70.209 | 0.009 | 6.837 | 0 |
| Other Investing Activites
| 0.002 | 5.86 | -58.583 | 3.712 | 1.457 | 0.001 | 73.814 | 6.942 | 19.984 | 6.502 |
| Investing Cash Flow
| -420.171 | -99.008 | -129.347 | -105.912 | -382.154 | -109.983 | -84.86 | -12.279 | -0.921 | -21.922 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -300.801 | -536.925 | -31.498 | -2.283 | -224.084 | -98.101 | -66.58 | -12.544 | -22.591 | -16.696 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 107.52 | 0.12 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -56.532 | -116.833 | -47.379 | -43.072 | -41.457 | 0 | 0 | 0 | -0.09 | -5.633 |
| Other Financing Activities
| -33.074 | 453.99 | -2.102 | 31.265 | 449.503 | 155.03 | 58.484 | -43.384 | -32.932 | 25.334 |
| Financing Cash Flow
| 237.612 | -199.768 | -80.979 | -14.09 | 183.962 | 164.449 | -7.976 | -55.928 | -55.613 | 3.005 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| -0.002 | -0.152 | 1.071 | -0.617 | 0.132 | 0.049 | -0.053 | 0.022 | 0.03 | 0.003 |
| Net Change In Cash
| 7.697 | -10.395 | 41.114 | 11.308 | -97.447 | 213.643 | -6.153 | 8.593 | -16.127 | 35.342 |
| Cash At End Of Period
| 158.724 | 151.019 | 161.414 | 120.3 | 108.992 | 206.439 | -7.204 | -1.051 | -9.644 | 6.483 |